---
document_datetime: 2025-12-02 05:26:26
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/pregabalin-zentiva-ks.html
document_name: pregabalin-zentiva-ks.html
version: success
processing_time: 0.1059293
conversion_datetime: 2025-12-26 18:41:25.350133
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Pregabalin Zentiva k.s.

[RSS](/en/individual-human-medicine.xml/66730)

##### Withdrawn

This medicine's authorisation has been withdrawn

pregabalin Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Pregabalin Zentiva k.s.](#news-on)
- [Related information](#related-information-774)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 23 February 2023, the European Commission withdrew the marketing authorisation for Pregabalin Zentiva k.s. (pregabalin) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Zentiva k.s., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Pregabalin Zentiva k.s. was granted marketing authorisation in the EU on 27 February 2017 for the treatment of neuropathic pain, epilepsy and generalised anxiety disorder (GAD). The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2021.

Pregabalin Zentiva k.s. is a generic medicine of Lyrica. There are other generic medicinal products of Lyrica authorised and marketed in the EU.

The European Public Assessment Report (EPAR) for Pregabalin Zentiva k.s. is updated to indicate that the marketing authorisation is no longer valid.

Pregabalin Zentiva k.s. : EPAR - Summary for the public

Reference Number: EMA/14344/2017

English (EN) (708.49 KB - PDF)

**First published:** 06/03/2017

**Last updated:** 20/03/2023

[View](/en/documents/overview/pregabalin-zentiva-ks-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-30)

български (BG) (782.42 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/bg/documents/overview/pregabalin-zentiva-ks-epar-summary-public_bg.pdf)

español (ES) (688.24 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/es/documents/overview/pregabalin-zentiva-ks-epar-summary-public_es.pdf)

čeština (CS) (760.85 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/cs/documents/overview/pregabalin-zentiva-ks-epar-summary-public_cs.pdf)

dansk (DA) (686.37 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/da/documents/overview/pregabalin-zentiva-ks-epar-summary-public_da.pdf)

Deutsch (DE) (691.63 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/de/documents/overview/pregabalin-zentiva-ks-epar-summary-public_de.pdf)

eesti keel (ET) (686.8 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/et/documents/overview/pregabalin-zentiva-ks-epar-summary-public_et.pdf)

ελληνικά (EL) (786.71 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/el/documents/overview/pregabalin-zentiva-ks-epar-summary-public_el.pdf)

français (FR) (689.75 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/fr/documents/overview/pregabalin-zentiva-ks-epar-summary-public_fr.pdf)

hrvatski (HR) (706.01 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/hr/documents/overview/pregabalin-zentiva-ks-epar-summary-public_hr.pdf)

italiano (IT) (687.47 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/it/documents/overview/pregabalin-zentiva-ks-epar-summary-public_it.pdf)

latviešu valoda (LV) (759.11 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/lv/documents/overview/pregabalin-zentiva-ks-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (709.48 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/lt/documents/overview/pregabalin-zentiva-ks-epar-summary-public_lt.pdf)

magyar (HU) (754.53 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/hu/documents/overview/pregabalin-zentiva-ks-epar-summary-public_hu.pdf)

Malti (MT) (761.91 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/mt/documents/overview/pregabalin-zentiva-ks-epar-summary-public_mt.pdf)

Nederlands (NL) (688.22 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/nl/documents/overview/pregabalin-zentiva-ks-epar-summary-public_nl.pdf)

polski (PL) (758.56 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/pl/documents/overview/pregabalin-zentiva-ks-epar-summary-public_pl.pdf)

português (PT) (689.09 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/pt/documents/overview/pregabalin-zentiva-ks-epar-summary-public_pt.pdf)

română (RO) (710.07 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/ro/documents/overview/pregabalin-zentiva-ks-epar-summary-public_ro.pdf)

slovenčina (SK) (758.37 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/sk/documents/overview/pregabalin-zentiva-ks-epar-summary-public_sk.pdf)

slovenščina (SL) (751.27 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/sl/documents/overview/pregabalin-zentiva-ks-epar-summary-public_sl.pdf)

Suomi (FI) (688.13 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/fi/documents/overview/pregabalin-zentiva-ks-epar-summary-public_fi.pdf)

svenska (SV) (687.59 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/sv/documents/overview/pregabalin-zentiva-ks-epar-summary-public_sv.pdf)

Pregabalin Zentiva k.s. : EPAR - Risk management plan summary

English (EN) (718.86 KB - PDF)

**First published:** 05/05/2022

**Last updated:** 20/03/2023

[View](/en/documents/rmp-summary/pregabalin-zentiva-ks-epar-risk-management-plan-summary_en.pdf)

## Product information

Pregabalin Zentiva k.s. : EPAR - Product Information

English (EN) (1.25 MB - PDF)

**First published:** 06/03/2017

**Last updated:** 20/03/2023

[View](/en/documents/product-information/pregabalin-zentiva-ks-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-273)

български (BG) (2.79 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/bg/documents/product-information/pregabalin-zentiva-ks-epar-product-information_bg.pdf)

español (ES) (1.33 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/es/documents/product-information/pregabalin-zentiva-ks-epar-product-information_es.pdf)

čeština (CS) (2.31 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/cs/documents/product-information/pregabalin-zentiva-ks-epar-product-information_cs.pdf)

dansk (DA) (1.29 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/da/documents/product-information/pregabalin-zentiva-ks-epar-product-information_da.pdf)

Deutsch (DE) (1.29 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/de/documents/product-information/pregabalin-zentiva-ks-epar-product-information_de.pdf)

eesti keel (ET) (1.26 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/et/documents/product-information/pregabalin-zentiva-ks-epar-product-information_et.pdf)

ελληνικά (EL) (2.99 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/el/documents/product-information/pregabalin-zentiva-ks-epar-product-information_el.pdf)

français (FR) (1.4 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/fr/documents/product-information/pregabalin-zentiva-ks-epar-product-information_fr.pdf)

hrvatski (HR) (1.4 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/hr/documents/product-information/pregabalin-zentiva-ks-epar-product-information_hr.pdf)

íslenska (IS) (1.26 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/is/documents/product-information/pregabalin-zentiva-ks-epar-product-information_is.pdf)

italiano (IT) (1.38 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/it/documents/product-information/pregabalin-zentiva-ks-epar-product-information_it.pdf)

latviešu valoda (LV) (2.35 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/lv/documents/product-information/pregabalin-zentiva-ks-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.45 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/lt/documents/product-information/pregabalin-zentiva-ks-epar-product-information_lt.pdf)

magyar (HU) (2.32 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/hu/documents/product-information/pregabalin-zentiva-ks-epar-product-information_hu.pdf)

Malti (MT) (2.49 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/mt/documents/product-information/pregabalin-zentiva-ks-epar-product-information_mt.pdf)

Nederlands (NL) (1.35 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/nl/documents/product-information/pregabalin-zentiva-ks-epar-product-information_nl.pdf)

norsk (NO) (1.33 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/no/documents/product-information/pregabalin-zentiva-ks-epar-product-information_no.pdf)

polski (PL) (2.6 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/pl/documents/product-information/pregabalin-zentiva-ks-epar-product-information_pl.pdf)

português (PT) (1.27 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/pt/documents/product-information/pregabalin-zentiva-ks-epar-product-information_pt.pdf)

română (RO) (1.39 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/ro/documents/product-information/pregabalin-zentiva-ks-epar-product-information_ro.pdf)

slovenčina (SK) (2.44 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/sk/documents/product-information/pregabalin-zentiva-ks-epar-product-information_sk.pdf)

slovenščina (SL) (2.26 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/sl/documents/product-information/pregabalin-zentiva-ks-epar-product-information_sl.pdf)

Suomi (FI) (1.26 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/fi/documents/product-information/pregabalin-zentiva-ks-epar-product-information_fi.pdf)

svenska (SV) (1.26 MB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/sv/documents/product-information/pregabalin-zentiva-ks-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0022/G 23/02/2023

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Pregabalin Zentiva k.s. : EPAR - All Authorised presentations

English (EN) (639.03 KB - PDF)

**First published:** 06/03/2017

**Last updated:** 20/03/2023

[View](/en/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-395)

български (BG) (745.4 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/bg/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_bg.pdf)

español (ES) (731.51 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/es/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_es.pdf)

čeština (CS) (675.61 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/cs/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (600.96 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/da/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (629.77 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/de/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (652.91 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/et/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (642.76 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/el/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_el.pdf)

français (FR) (634.26 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/fr/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (648.73 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/hr/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (632.46 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/is/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_is.pdf)

italiano (IT) (634.26 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/it/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (719.05 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/lv/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (631.32 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/lt/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (664.87 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/hu/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (747.2 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/mt/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (662.04 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/nl/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (632.35 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/no/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_no.pdf)

polski (PL) (717.32 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/pl/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_pl.pdf)

português (PT) (622.13 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/pt/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_pt.pdf)

română (RO) (627.33 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/ro/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (721.55 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/sk/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (631.61 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/sl/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (627.16 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/fi/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (612.2 KB - PDF)

**First published:**

06/03/2017

**Last updated:**

20/03/2023

[View](/sv/documents/all-authorised-presentations/pregabalin-zentiva-ks-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Pregabalin Zentiva k.s. Active substance pregabalin International non-proprietary name (INN) or common name pregabalin Therapeutic area (MeSH)

- Anxiety Disorders
- Neuralgia
- Epilepsy

Anatomical therapeutic chemical (ATC) code N03AX16

### Pharmacotherapeutic group

Antiepileptics

### Therapeutic indication

**Neuropathic pain**

- Pregabalin Zentiva k.s. is indicated for the treatment of peripheral and central neuropathic pain in adults.

**Epilepsy**

- Pregabalin Zentiva k.s. is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

**Generalised anxiety disorder**

- Pregabalin Zentiva k.s. is indicated for the treatment of generalised anxiety disorder (GAD) in adults.

## Authorisation details

EMA product number EMEA/H/C/004277

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Zentiva k.s.

U Kabelovny 130 102 37  Prague 10 Czech Republic

Opinion adopted 15/12/2016 Marketing authorisation issued 27/02/2017 Revision 13

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Pregabalin Zentiva k.s. : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (811.02 KB - PDF)

**First published:** 05/02/2018

**Last updated:** 20/03/2023

[View](/en/documents/procedural-steps-after/pregabalin-zentiva-ks-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Pregabalin Zentiva k.s. : EPAR - Public assessment report

Adopted

Reference Number: EMA/14344/2017

English (EN) (1017.54 KB - PDF)

**First published:** 06/03/2017

**Last updated:** 20/03/2023

[View](/en/documents/assessment-report/pregabalin-zentiva-ks-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Pregabalin Zentiva k.s.

Adopted

Reference Number: EMA/CHMP/643488/2016

English (EN) (645.44 KB - PDF)

**First published:** 16/12/2016

**Last updated:** 20/03/2023

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-pregabalin-zentiva-ks_en.pdf)

#### News on Pregabalin Zentiva k.s.

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2016](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-december-2016) 16/12/2016

#### Related information

- [Clinical data](https://clinicaldata.ema.europa.eu/web/cdp/home?p_p_id=cdpdossierviewportlet_WAR_cdpdossierviewportlet=0=maximized=view=column-3=2=EMEAHC0042770000) (initial marketing authorisation)

**This page was last updated on** 20/03/2023

## Share this page

[Back to top](#main-content)